NL-OMON33541尚未招募不适用
The Effect of Inhaled Salmeterol on Inflammation after Bronchial Instillation of Allergen or Allergen/Lipopolysaccharide in Asthma. - Effect of Salmeterol on Allergic Inflammation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •* Intermittent to mild asthmatics between 18 and 45 years of age
- •* Allergy for house dust mite documented by a positive RAST
- •* No clinically significant findings during physical examination and hematological and biochemical screening
- •* At spirometry FEV1 more than 70% of predicted value
- •* Stable asthma while treated with fluticasone propionate 100*g bid during 2 weeks before the study.
排除标准
- •* Comorbidity
- •* A history of smoking within the last 12 months, or regular consumption of greater than three units of alcohol per day
- •* Exacerbation and/or the use of oral steroids within the 4 weeks before start of run in.
- •* Administration of any investigational drug within 30 days of study initiation
- •* Donation of blood within 60 days, or loss of greater than 400 ml of blood within 12 weeks of study initiation
- •* History of enhanced bleeding tendency
- •* History of serious drug-related reactions, including hypersensitivity
- •* Inability to use only the run-in medication plus salbutamol rescue medication supplied for this study. If subjects use other pulmonary medications these will be replaced by the run-in medication.
研究者
相似试验
已完成
不适用
The Effect of Inhaled Salmeterol on Inflammation after Bronchial Instillation of Allergen or Allergen/Lipopolysaccharide in Asthma.Mild asthma, allergen induced inflammationNL-OMON26298Academic Medical Center Amsterdam, dept. Pulmonology32
已完成
不适用
The efficacy of salmeterol/fluticasone inhalation on systemic inflammatory markers in patients with chronic obstructive pulmonary diseaseschronic obstructive pulmonary diseasesJPRN-UMIN000008102Kawasaki Medical School60
进行中(未招募)
1 期
ptake and excretion of salmeterol in healthy trained malesEUCTR2014-002139-33-DKBispebjerg University Hospital
进行中(未招募)
不适用
Effects of bronchodilatation with salmeterol on the autonomic nervous systemChronic Obstructive Pulmonary Disease (COPD)MedDRA version: 14.1Level: LLTClassification code 10010952Term: COPDSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-001581-18-DEGlaxoSmithKline GmbH & Co. KG
已完成
4 期
Investigation of inhaled Salmeterol/ Fluticasone propionate (SFC) in patient with COPD.Chronic obstructive pulmonary diseaseJPRN-UMIN000006589Hamamatsu University School of Medicine342
